Wolfspeed shares are rallying some 24% during Monday's session. The stock is now higher by 68% over the past week, despite a lack of any new company-specific news.
A lawsuit claims Eli Lilly, Johnson & Johnson, and Kaiser Permanente failed to warn consumers about breast cancer risks linked to their antipsychotic drugs Risperdal and Zyprexa.
Record outflows from sustainable investment vehicles reflect growing skepticism and potential long-term opportunities, as investors recalibrate ESG strategies.
Shares of exercise equipment company Peloton (NASDAQ:PTON)
jumped 6.4% in the pre-market session after Truist analysts upgraded the stock's rating from Hold to Buy, signaling renewed confidence in the company's turnaround efforts. In their note, the firm emphasized that more than three years after initially downgrading Peloton, they saw tangible improvements in the company's fundamentals.
Sony Group Corp is considering spinning off its semiconductor unit Sony Semiconductor Solutions Corp by 2025 and may also spin off its financial arm. Intel recently sold a stake in its chip business.
